{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:12:22Z","timestamp":1788880342113,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022098","name":"Mito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K99HD109359"],"award-info":[{"award-number":["K99HD109359"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031370","name":"Taysha Gene Therapies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028921","name":"RTW Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101554","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:23:24Z","timestamp":1754925804000},"page":"101554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Improved AAV9-based gene therapy design for SURF1-related Leigh syndrome with minimal toxicity"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-975X","authenticated-orcid":false,"given":"Qinglan","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett E.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-8621","authenticated-orcid":false,"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101554_bib1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: One disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2025.101554_bib2","first-page":"1188","article-title":"Leigh Syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings","volume":"24","author":"Rossi","year":"2003","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.omtm.2025.101554_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/3804","article-title":"SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome","volume":"20","author":"Zhu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2025.101554_bib4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1086\/302150","article-title":"Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency","volume":"63","author":"Tiranti","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101554_bib5","doi-asserted-by":"crossref","first-page":"25735","DOI":"10.1074\/jbc.M109.040295","article-title":"Surf1, associated with Leigh syndrome in humans, is a heme-binding protein in bacterial oxidase biogenesis","volume":"284","author":"Bundschuh","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101554_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbabio.2011.09.007","article-title":"Role of Surf1 in heme recruitment for bacterial COX biogenesis","volume":"1817","author":"Hannappel","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2025.101554_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/hmg\/ddg038","article-title":"Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice","volume":"12","author":"Agostino","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101554_bib8","first-page":"194","article-title":"Missense mutations in SURF1 associated with deficient cytochrome c oxidase assembly in Leigh syndrome patients","volume":"106","author":"Poyau","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtm.2025.101554_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-96","article-title":"SURF1 deficiency: a multi-centre natural history study","volume":"8","author":"Wedatilake","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2025.101554_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63947","article-title":"SURF1 Deficiency: Expanding on Disease Phenotype and Assessing Disease Burden by Describing Clinical and Biochemical Phenotype","volume":"197","author":"Kayani","year":"2025","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtm.2025.101554_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2025.101554_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omtm.2021.09.001","article-title":"Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome","volume":"23","author":"Ling","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101554_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(02)00878-8","article-title":"Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites","volume":"297","author":"Tornoe","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.omtm.2025.101554_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146286","article-title":"AAV9\/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease","volume":"132","author":"Chen","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101554_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-018-9234-0","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.omtm.2025.101554_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.mt.6300355","article-title":"Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose","volume":"16","author":"Wu","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.672449","article-title":"Effect of CpG Depletion of Vector Genome on CD8(+) T Cell Responses in AAV Gene Therapy","volume":"12","author":"Bertolini","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101554_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41434-024-00498-2","article-title":"Expression and distribution of rAAV9 intrathecally administered in juvenile to adolescent mice","volume":"32","author":"Garza","year":"2025","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ymthe.2020.11.012","article-title":"Pre-clinical gene therapy with AAV9\/AGA in aspartylglucosaminuria mice provides evidence for clinical translation","volume":"29","author":"Chen","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib20","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/s44321-024-00111-4","article-title":"Restoration of defective oxidative phosphorylation to a subset of neurons prevents mitochondrial encephalopathy","volume":"16","author":"Walker","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2025.101554_bib21","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1074\/jbc.M112.422220","article-title":"hCOA3 stabilizes cytochrome c oxidase 1 (COX1) and promotes cytochrome c oxidase assembly in human mitochondria","volume":"288","author":"Clemente","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101554_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","article-title":"The power and potential of mitochondria transfer","volume":"623","author":"Borcherding","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101554_bib23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.omtm.2022.01.013","article-title":"Characterization of AAV-mediated dorsal root ganglionopathy","volume":"24","author":"Buss","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101554_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164575","article-title":"Intrathecal AAV9\/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies","volume":"133","author":"Chen","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101554_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.omtm.2022.02.002","article-title":"In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency","volume":"24","author":"Huichalaf","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101554_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrm.2017.110","article-title":"The mitochondrial UPR: mechanisms, physiological functions and implications in ageing","volume":"19","author":"Shpilka","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2025.101554_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1873-3468.12894","article-title":"mPOS is a novel mitochondrial trigger of cell death - implications for neurodegeneration","volume":"592","author":"Coyne","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2025.101554_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/hmg\/ddl477","article-title":"Increased longevity and refractoriness to Ca2+-dependent neurodegeneration in Surf1 knockout mice","volume":"16","author":"Dell'Agnello","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101554_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/gt.2011.130","article-title":"Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs","volume":"19","author":"Federici","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146832","article-title":"Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies","volume":"1739","author":"Bailey","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.omtm.2025.101554_bib35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2016.013","article-title":"Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease","volume":"27","author":"Karumuthil-Melethil","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/hum.2022.163","article-title":"Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed Administration","volume":"34","author":"Chen","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101554_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Cl\u00e9ment","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101554_bib39","first-page":"4.17.11","article-title":"Production of Recombinant Adeno-Associated Viral Vectors and Use in In Vitro and In Vivo Administration","volume":"57","author":"Gray","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.omtm.2025.101554_bib40","first-page":"4.17.11","article-title":"Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration","volume":"57","author":"Gray","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.omtm.2025.101554_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nprot.2006.478","article-title":"Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts","volume":"2","author":"Frezza","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2025.101554_bib42","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nprot.2008.105","article-title":"Isolation of mitochondria from rat brain using Percoll density gradient centrifugation","volume":"3","author":"Sims","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2025.101554_bib43","doi-asserted-by":"crossref","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","article-title":"MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations","volume":"49","author":"Rath","year":"2021","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:25:40Z","timestamp":1762615540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001494"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101554","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved AAV9-based gene therapy design for SURF1-related Leigh syndrome with minimal toxicity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101554","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101554"}}